UBS Group
BCDA icon

UBS Group’s BioCardia BCDA Stock Holding History

UBS Group’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.2K Buy
+77,619
New +$81.8K ﹤0.01% 7213
2026
Q1 		– Sell
-4,423
Closed -$5.53K – 10490
2025
Q4 		$5.53K Sell
4,423
-6,317
-59% -$8.58K ﹤0.01% 8669
2025
Q3 		$13.9K Buy
10,740
+6,561
+157% +$12.8K ﹤0.01% 8384
2025
Q2 		$8.15K Sell
4,179
-423
-9% -$941 ﹤0.01% 8974
2025
Q1 		$11.7K Sell
4,602
-148
-3% -$358 ﹤0.01% 8536
2024
Q4 		$10.4K Buy
+4,750
New +$11.1K ﹤0.01% 8303
2023
Q3 		– Sell
-41
Closed -$1.64K – 9454
2023
Q2 		$1.64K Sell
41
-29
-41% -$894 ﹤0.01% 7881
2023
Q1 		$2.04K Sell
70
-453
-87% -$15K ﹤0.01% 8597
2022
Q4 		$16.4K Buy
523
+404
+339% +$11.5K ﹤0.01% 7908
2022
Q3 		$3K Sell
119
-213
-64% -$5.51K ﹤0.01% 9514
2022
Q2 		$7K Buy
332
+219
+194% +$5.24K ﹤0.01% 8453
2022
Q1 		$4K Sell
113
-275
-71% -$8.17K ﹤0.01% 9270
2021
Q4 		$11K Buy
+388
New +$14.2K ﹤0.01% 8657
2021
Q3 		– Sell
-250
Closed -$15K – 9527
2021
Q2 		$15K Buy
+250
New +$15.2K ﹤0.01% 7636
2021
Q1 		– Sell
-290
Closed -$15K – 8991
2020
Q4 		$15K Buy
+290
New +$11.6K ﹤0.01% 7150
2020
Q2 		– Sell
-17
Closed -$1K – 7934
2020
Q1 		$1K Sell
17
-173
-91% -$10.7K ﹤0.01% 7732
2019
Q4 		$10K Buy
+190
New +$11.2K ﹤0.01% 7273

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group's BCDA Position: Q2 2026 in Review

UBS Group opened a new position in BioCardia (BCDA) in Q2 2026: 77,619 shares worth $96.2K. The stake represents ﹤0.01% of the portfolio and ranks #7213 among its holdings. This is a return to the name: UBS Group previously reported a position in BCDA as recently as Q4 2025.

UBS Group first reported a position in BCDA in Q4 2019 and has held it in 17 quarters since. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • UBS Group held 77,619 shares of BioCardia worth $96.2K as of Q2 2026.
  • BioCardia was a new UBS Group position in Q2 2026.
  • BioCardia made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7213 holding.
  • UBS Group first reported a position in BioCardia in Q4 2019 and has held it in 17 quarters since.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.